研究業績RESEARCH ACHIEVEMENT
持塚先生の基礎研究の論文がScientific reportsに掲載されました。他、各先生の論文が掲載されました。
呼吸器内科
2026.02.18
-基礎研究-
（持塚先生）
Mochizuka Y, Hozumi H, Watanabe H, Fukada A, Naoi H, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis. Sci Rep. 2026 Feb 11. doi: 10.1038/s41598-026-39649-3. Epub ahead of print. PMID: 41667819.
-臨床研究-
（北原先生）
Kitahara Y, Fujisawa T, Fukada A, Koda K, Akamatsu T, Ikeda M, Fujii M, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yamashita K, Iwaizumi M, Maekawa M, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD. Sci Rep. 2026 Jan 24;16(1):6134. doi: 10.1038/s41598-026-37104-x. PMID: 41577954; PMCID: PMC12901154.
（宮下先生）
Miyashita K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakatani E, Inui N, Ojima T, Suda T. Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis. Respir Investig. 2026 Jan 8;64(2):101367. doi: 10.1016/j.resinv.2026.101367. Epub ahead of print. PMID: 41512642.
（森川先生）
Morikawa K, Suzuki Y, Kato S, Kono M, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study. Sci Rep. 2025 Dec 15;15(1):43859. doi: 10.1038/s41598-025-27730-2. PMID: 41398196; PMCID: PMC12706045.
-Case report-
（中井先生）
Nakai S, Inoue Y, Karayama M, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case report. Respir Med Case Rep. 2025 Oct 17;58:102304. doi: 10.1016/j.rmcr.2025.102304. PMID: 41292556; PMCID: PMC12641558.
（持塚先生）
Mochizuka Y, Hozumi H, Watanabe H, Fukada A, Naoi H, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis. Sci Rep. 2026 Feb 11. doi: 10.1038/s41598-026-39649-3. Epub ahead of print. PMID: 41667819.
-臨床研究-
（北原先生）
Kitahara Y, Fujisawa T, Fukada A, Koda K, Akamatsu T, Ikeda M, Fujii M, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yamashita K, Iwaizumi M, Maekawa M, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD. Sci Rep. 2026 Jan 24;16(1):6134. doi: 10.1038/s41598-026-37104-x. PMID: 41577954; PMCID: PMC12901154.
（宮下先生）
Miyashita K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakatani E, Inui N, Ojima T, Suda T. Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis. Respir Investig. 2026 Jan 8;64(2):101367. doi: 10.1016/j.resinv.2026.101367. Epub ahead of print. PMID: 41512642.
（森川先生）
Morikawa K, Suzuki Y, Kato S, Kono M, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study. Sci Rep. 2025 Dec 15;15(1):43859. doi: 10.1038/s41598-025-27730-2. PMID: 41398196; PMCID: PMC12706045.
-Case report-
（中井先生）
Nakai S, Inoue Y, Karayama M, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case report. Respir Med Case Rep. 2025 Oct 17;58:102304. doi: 10.1016/j.rmcr.2025.102304. PMID: 41292556; PMCID: PMC12641558.